|
|
||||||||
Journal of Applied Physiology, Vol 65, Issue 3 1351-1359, Copyright © 1988 by American Physiological Society
ARTICLES |
J. W. Coggeshall, B. W. Christman, P. L. Lefferts, W. E. Serafin, I. A. Blair, M. J. Butterfield and J. R. Snapper
Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.
We studied the effects of a 5-lipoxygenase inhibitor, L-651,192, on the pulmonary dysfunction caused by endotoxemia in chronically instrumented unanesthetized sheep. The efficacy and selectivity of L-651,392 were tested by measuring in vivo production of leukotriene B4 (LTB4) and cyclooxygenase products of arachidonic acid after endotoxemia before and after pretreatment with L-651,392 and ex vivo from granulocytes and whole blood stimulated with calcium ionophore from sheep before and 24 h after pretreatment with L-651,392. A novel assay for LTB4 by high-performance liquid chromatography/gas chromatography/mass spectrometry techniques was developed as a measure of 5-lipoxygenase metabolism of arachidonic acid. L-651,392 proved to be an effective in vivo 5-lipoxygenase inhibitor in sheep. L-651,392 blocked the increase in LTB4 observed in lung lymph after endotoxemia in vivo in sheep as well as inhibited by 80% the ex vivo production of LTB4 by granulocytes removed from sheep treated 24 h earlier with L-651,392. Although L-651,392 blocked the increase in cyclooxygenase products of arachidonic acid observed in lung lymph after endotoxemia in vivo in sheep, the drug probably did not function directly as a cyclooxygenase inhibitor. L-651,392 did not attenuate the ex vivo production of thromboxane B2 by whole blood from sheep treated 24 h earlier with the drug. L-651,392 attenuated the alterations in pulmonary hemodynamics, lung mechanics, oxygenation, and lung fluid and solute exchange observed after endotoxemia in sheep. We speculate that 5-lipoxygenase products are a major stimulus for cyclooxygenase metabolism of arachidonic acid after endotoxemia in sheep.
This article has been cited by other articles:
![]() |
E.D. Moloney and T.W. Evans Pathophysiology and pharmacological treatment of pulmonary hypertension in acute respiratory distress syndrome Eur. Respir. J., April 1, 2003; 21(4): 720 - 727. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Sheridan A Great Constitutional Disturbance N. Engl. J. Med., October 25, 2001; 345(17): 1271 - 1272. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |